In addition, it has been reported that TD patients have increased angiopoietin related protein 3 (ANGPTL3), which is an inhibitor of lipoprotein lipase (LPL), and influences HDL and TG metabolism [37]. The gene discussed is LPL; the disease is thanatophoric dysplasia.